What we noticed at Beauty Expo Australia 2026, and the questions we left with

I said I would write up what I actually saw across the weekend, so this is that piece, put together from two days on the floor at ICC Sydney and a great many conversations at D135. Four things stood out, and not one of them resolves neatly, so what follows is as much a set of open questions about where this industry is heading as it is a report on what was there.

The most interesting movement on the floor this year arrived with a country attached to it. J-Beauty, meaning Japanese beauty, turned up at Beauty Expo Australia with a real spread of stands, and it turned up carrying a philosophy that sits at a deliberate angle to the one the Australian market has spent the past three years absorbing.

What J-Beauty is actually selling

If K-Beauty taught the Australian consumer to build a routine, J-Beauty is asking her to take things out of one. The philosophy runs on less being more, held up by high-tech scientific precision and heritage ingredients that have been in professional use for centuries, and pointed at a long-term preventative outcome rather than a visible result by Friday. Where K-Beauty has moved on trend cycles and multi-step routines, J-Beauty builds around gentleness and barrier support, with skin health held steady across years. The outcome it sells is mochi skin, named after the Japanese rice cake, which describes skin that is plump and bouncy with a softness you can see before you touch it.

That distinction matters commercially, and it matters most in our channel. A trend-driven routine gives a client a reason to try the next thing, and a preventative philosophy gives her a reason to come back to the same therapist for the next five years. One of those two models is considerably better suited to a business that lives on rebooking rates and retail attachment, and it is not the one that changes every quarter. J-Beauty arrives with a story a therapist can build a treatment plan around, and a retail ladder where the next rung is obvious.

K-Beauty has gone from an aisle to almost three

Last year, K-Beauty occupied roughly an aisle of the floor. This year it occupied close to three, which is about as clean a measure of penetration into the Australian professional channel as anyone could ask for. What was a curiosity two years ago is now a category with distribution behind it and buyers walking the floor with it specifically on their lists.

Our own search data earlier this year pointed to the same conclusion from the consumer side. Searches in Australia for PDRN grew 490 per cent year on year, copper peptides 344 per cent, and exosomes 183 per cent. Australian clients are asking for these actives by name, at two in the morning, long before they ever book a consultation. The brands filling those aisles at ICC Sydney are the ones that made the name of the active the name of the product.

The question this leaves for Australian brands

This is what I could not stop asking people about across the weekend, and it is the one I would like your answer to. Advanced Skin Technology, INSKIN Cosmedics, Synergie Skin, and the rest of the Australian cosmedical field have spent years building positions on clinical credibility and formulation integrity, and they have done it well enough that our market is unusually literate about actives compared with most of the world. They now sit in front of a fairly stark strategic choice.

The first option is to formulate the incoming actives into their own ranges and meet demand where the consumer already is, which protects shelf space and answers the question the client is asking, while carrying the risk of looking like a follower in a category built on being first. The second is to hold the existing position, let the imported brands sit alongside them on the same shelf, and leave the stockist to make her own mind up about what her client base actually wants, which protects the brand story and hands a meaningful amount of category authority to somebody else.

The third answer, which was already on the floor

O Cosmedics launched Clinical Care, a range of nine face and body products designed to support the skin's barrier by soothing inflammation, relieving dryness, and promoting skin recovery. It is built for people managing mild eczema, psoriasis, or dermatitis, which is to say the clients who have spent years cycling through products and well-meaning advice and have never been able to work out who to trust. The part worth paying attention to is that the range is professional only and practitioner prescribed.

Consider what that decision pushes back against. The line between professional and retail has been eroding from both directions for several years now, with professional brands moving into retail spaces to chase volume, and retail brands moving into the treatment room with devices, protocols, and language borrowed wholesale from clinical skincare. Most of the industry has treated that blur as weather, meaning something that happens to you rather than something you have a position on. Launching a barrier-first range that a client cannot buy without a practitioner is a decision to hold the line and to make the therapist the reason the product works at all.

The formulation direction is worth sitting with as well. O built its name on functional doses of actives working at the threshold of medicine, so a range that leads with calm and recovery rather than correction is a different proposition from the one the brand is known for. Read it alongside the J-Beauty philosophy and the overlap is hard to miss, which makes Clinical Care the first substantial answer I have seen from an Australian house to the question the imported brands are asking.

What the imported brands have brought with them is the language. J-Beauty gives an idea like barrier-first skincare a name, an aesthetic, an outcome the client can picture, and a reason to care about it this year. That is a positioning advantage, and it is the part of this the Australian field should be moving on fastest, because language is considerably cheaper to build than a formulation programme. Whoever gets to it first here can hold it in terms a client understands, and stand on local supply and the practitioner relationship in a way that an imported range on a distributor's second-tier account cannot match.

The fragrance question nobody has answered yet

The other footprint that grew was fragrance. The Dubai houses were at the expo last year with a presence, and this year they had roughly four times the space, which is the sort of increase that comes with a budget and a plan behind it rather than a punt.

What I cannot work out is which plan. One reading is that the expo has become a retail opportunity in its own right, with thousands of beauty professionals walking past who will happily buy an oud for themselves on a Saturday, and the stand pays for itself without a single wholesale account opening. The other reading is that there is a distribution agenda underneath it, and the ambition is to have salons and clinics stocking fragrance as a retail line the way they stock candles and body care now.

Both are plausible and they lead to very different years. Fragrance as a salon retail line carries real appeal, because the margin is good, there is no consultation liability attached to it, nothing expires on the shelf, and it sells to a client who is already in an excellent mood on her way out the door. Against that, it does nothing for her skin outcome, it does not deepen the reason she comes back to you specifically, and it takes shelf space from product that supports the service you have just performed. If you were approached by one of those stands about wholesale, I would very much like to hear about it, because that answers the question properly.

What this means for the clinic

If you stock Australian cosmedical brands and you have been watching the K-Beauty aisles grow with some anxiety, the useful move is probably not a wholesale change to your shelf. Your clients are already searching these actives, so the gap in the business is more likely to be the conversation than the inventory. Being able to explain to a client why her barrier comes before her retinol, in terms she can repeat to her friends, is worth more than another brand on the wall.

If you are a brand, the question to settle before the next selling season is whether you are answering demand or defining it. Both are legitimate positions and both can be defended commercially, and the thing that damages a brand is drifting between them for eighteen months while a distributor decides on your behalf.

If you were at the expo, I would like to know what you saw. The floor was big enough this year that I am certain I missed things, and the follow-up conversations are usually where the real story sits. Reply and tell me which stands stopped you, and what you heard from other owners about how the year is actually going.

We will be pulling the weekend into the next State of Professional Beauty report alongside the search and revenue data, and the more of you who tell me what you saw, the better that report becomes for all of us.